Company news

Shanghai Rightongene Biotechnology Co. Ltd. news in 2025

Shanghai Rightongene Biotechnology Co. Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Announcement on Using Self-owned Funds to Pay Funds Required for Investment Projects Financed by Raised Funds and Replacing Them with an Equal Amount of Raised Funds

November 14, 2025

Notice on Convening the 4th Extraordinary General Meeting in 2025

October 28, 2025

Announcement on Implementation of Semi-annual Dividend Distribution for 2025

October 16, 2025

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025

October 10, 2025

Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License

October 9, 2025

Announcement on Resolutions of the 5th Meeting of the 3rd Board of Supervisors

September 23, 2025

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

September 16, 2025

Announcement on Personnel Adjustments and Changes

September 8, 2025

Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025

August 28, 2025

Announcement on Resolution of the 2024 Annual General Meeting

June 20, 2025

Announcement on Reply to Inquiry Letter for Information Disclosure Supervision of 2024 Annual Report

May 20, 2025

Announcement on Change of Sponsor Representative for Continuous Supervision

May 8, 2025

Report for Q1 2025

April 24, 2025

Announcement on Preliminary Earnings Estimate for 2024

February 27, 2025

Announcement on Obtaining Government Subsidy

February 24, 2025

Announcement on Implementation Results of Repurchasing Shares and Share Changes

February 19, 2025

Announcement on Progress in Repurchasing Shares through Call Auction

February 6, 2025

Announcement on Resolution of the 1st Meeting of the 2nd Board of Supervisors

January 27, 2025

Announcement on Provision and Reversal for Asset Impairment in the Second Half of 2024

January 17, 2025

Announcement on Adjusting Allowance for Independent Directors

January 10, 2025